Abstract
In this study, we found that invertebrate Aurora-A and Aurora-B kinases are highly divergent protein families from their chordate counterparts. Furthermore, while the Aurora-A family is ubiquitous among all vertebrates, the Aurora-B and Aurora-C families in humans arose from a gene duplication event in mammals. These findings show the importance of understanding evolutionary relationships in the interpretation and transference of knowledge from studies of model organism systems to human cellular biology. In addition, given the important role of Aurora kinases in cancer, evolutionary analysis and comparisons of ATP-binding domains suggest a rationale for designing dual action anti-tumor drugs that inhibit both Aurora-B and Aurora-C kinases.
Introduction
Aurora kinases (A, B, and C) are essential enzymes that manage the "traffic control" of chromosomes during cell division. Because they are critical for healthy mitosis, their malfunction is strongly linked to cancer, making them prime targets for a new class of anti-cancer drugs. However, a significant gap exists in our understanding of how closely human kinases resemble those in model organisms like fruit flies (Drosophila) or worms (C. elegans). While mammals possess three Aurora kinases, most invertebrates have only two, and fungi have just one. This study traces the evolutionary history of the Aurora family to determine the exact relationships across the tree of life and to provide a structural roadmap for improved drug design.
Methods
The researchers employed a multi-pronged computational approach to reconstruct the Aurora family tree. Phylogenetic trees were built using four statistical methods—Neighbor-Joining, Maximum Parsimony, Maximum Likelihood, and Bayesian inference—to ensure robust results. The study utilized protein and DNA sequences from GenBank, covering a wide taxonomic range including mammals (human, mouse, rat, pig, cow), cold-blooded vertebrates (frog, zebrafish, pufferfish), urochordates (sea squirt), invertebrates (fruit fly, nematode, mosquito), and various fungi and plants. To understand the implications for drug design, the sequences of human Aurora-B and C were mapped onto the 3D crystal structure of human Aurora-A, focusing on the 26 amino acid residues lining the ATP-binding pocket.
Results
Evolutionary Lineage and the "Orthology Trap"
The phylogenetic analysis revealed that the three vertebrate Aurora kinases likely evolved from a single ancestor found in urochordates. While Aurora-A branched off early, Aurora-B and C only split recently in mammalian history. In cold-blooded vertebrates like frogs and fish, there is only one "Aurora-BC" gene. Crucially, the "Aurora-A" and "Aurora-B" found in invertebrates are not direct equivalents (orthologs) of the human versions; instead, they are ancestral to the entire chordate group. This divergence suggests that functional data from these organisms must be interpreted with caution when applied to human biology.
Structural Conservation and Drug Design Rationale
Despite millions of years of evolution, the ATP-binding site—the functional region where drugs bind—is remarkably conserved. The study found that the active sites of human Aurora-B and C are identical at all 26 key residue positions. Only three residues in this pocket differ between Aurora-A and the B/C pair. This high degree of conservation between B and C provides a compelling rationale for the development of dual-action inhibitors that target both paralogs simultaneously while potentially sparing Aurora-A.
Discussion
These findings have significant implications for both basic research and clinical applications. The evolutionary divergence between vertebrate and invertebrate kinases highlights the importance of phylogenetic context when using model organisms. From a therapeutic perspective, the identical active sites of Aurora-B and C suggest that a dual-action inhibitor could be a highly viable and potentially more effective anti-tumor strategy. Future work is needed to explore the divergence of protein-protein interaction networks and the specialized role of Aurora-C in mammalian biology, as well as to refine the timing of duplication events as more genomic data from basal chordates becomes available.
Summary updated